SpineSmith Partners, LP acquired rights in spine for Tissue Genesis, Inc.'s adipose (fat) tissue derived cell technology. Tissue Genesis' TGI 100 cell isolation kits and TGI 1000 automated cell isolation systems will rapidly process autologous (patient-derived) adipose tissue and isolate large quantities of regenerative cells, which can be utilized to treat a number of spine related diseases (www.spinesmithusa.com) (the patient's own) to over three thousand patients," said Kevin Dunworth, founder of SpineSmith. "We believe stem cells to be the next frontier in spine surgery and the Tissue Genesis cell isolation system rapidly processes a small quantity of a patient's own fat tissue to produce large quantities of cells, including adult stem cells and microvascular cells."
About SpineSmith Partners, LP
SpineSmith Partners, LP (www.tissuegenesis.com)
is a Qualified High Technology Business (QHTB) in Honolulu, Hawaii that is seeking to develop innovative tissue engineering solutions and technology to address a range of therapeutic
areas including vascular, cardiovascular, orthopedic and veterinarian. The company expects its technology to isolate autologous adipose derived cells in less than two hours for delivery
of the cells at point-of-care for immediate patient needs.
Contact Information:
Keri Kimler
512 206 0770
info @ spinesmithusa.com
8140 North Mopac, Bldg II, Suite 120
Austin, Tx 78759